Medical specialists from France tagged as investigators in clinical trials studying Crohn Disease

Total 128 results

Adeline GERMAIN, MD,PhD
Seen in:
- Vandœuvre-lès-Nancy, CHRU Nancy
Trials:
- NCT03809728 (Principal Investigator)
Conditions:
Anne-Laure PELLETIER, MD
Seen in:
- Paris, Hopital Bichat
Trials:
- NCT04496063 (Principal Investigator)
Conditions:
- Crohn's Disease
Anthony Buisson
Seen in:
- Clermont-Ferrand, CHU Clermont Ferrand
- Clermont-Ferrand, CHU Estaing
- Clermont-Ferrand, CHU de CLERMONT FERRAND- Hopital Estain
- Clermont-Ferrand, CHU de Clermont Ferrand - Hopital Estaing
- Clermont-Ferrand, CHU de Clermont-Ferrand
- Clermont-Ferrand, CHU de Clermont-Ferrand - Hôpital d'Estaing
- Clermont-Ferrand, Centre Hospitalier Universitaire de Clermont-Ferrand
- Clermont-Ferrand, Clermont-Ferrand University Hospital
Trials:
- NCT04183608 (Principal Investigator)
- NCT04973423 (Principal Investigator)
- NCT05903066 (Principal Investigator)
- NCT06254950 (Principal Investigator)
- NCT03679546 (Principal Investigator)
- NCT02425852 (Principal Investigator)
- NCT04496063 (Principal Investigator)
- NCT04064697 (Principal Investigator)
Conditions:
Antony Buisson, MD
Seen in:
- Amiens, CHU Amiens
Trials:
- NCT05040464 (Principal Investigator)
Conditions:
Arnaud BOUREILLE, MD PhD
Seen in:
- Amiens, CHU Amiens
- Nantes, Hôpital Hotel Dieu
Trials:
- NCT04496063 (Principal Investigator)
- NCT05040464 (Principal Investigator)
Conditions:
Barbara ROHMER, MD
Seen in:
- Bron, Service Hépatologie, Gastroentérologie et Nutrition pédiatrique, Hôpital Femme Mère Enfant, HCL
Trials:
- NCT05842564 (Sub-Investigator)
Conditions:
- Crohn Disease;
- Pediatric Crohns Disease
Béatrice VINSON-BONNET, MD
Seen in:
- Poissy, Hôpital de Poissy
Trials:
- NCT01388257 (Principal Investigator)
Conditions:
- Fistula;
- Crohn Disease;
- Anal Fistula;
- Anoperineal Fistula
Benjamin PARIENTE, MD, PhD
Seen in:
- Amiens, CHU Amiens
- Lille, CHRU Lille
- Lille, Lille Hôpital Huriez
Trials:
- NCT02425852 (Principal Investigator)
- NCT04496063 (Principal Investigator)
- NCT02839317 (Sub-Investigator)
- NCT05040464 (Principal Investigator)
Conditions:
Benoît Coffin
Seen in:
- Colombes, APHP - Hôpital Louis Mourier
- Colombes, Hôpital Louis Mourier
- Ile-de-France, Colombes, Hôpital Louis Mourier - Department of Hepato-Gastroentérologie
Trials:
- NCT05903066 (Principal Investigator)
- NCT04496063 (Principal Investigator)
- NCT01388257 (Principal Investigator)
Conditions:
- Crohn Disease;
- Crohn's Disease;
- Fistula;
- Anal Fistula;
- Anoperineal Fistula
Bernard FLOURIE, MD, Prof.
Seen in:
- Pierre Benite, Service d'Hépato-Gastroentérologie, Centre Hospitalier Lyon-Sud, HCL
Trials:
- NCT03915262 (Sub-Investigator)
Conditions:
- Crohn Disease
Bruno BONAZ, PU-PH
Seen in:
- Grenoble, CHU de Grenoble
Trials:
- NCT01663142 (Principal Investigator)
Conditions:
- Crohn's Disease;
- Flammatory Bowel Disease
Camille Sautel
Seen in:
- Issoire, Issoire Hospital
Trials:
- NCT04973423 (Principal Investigator)
Conditions:
- MRI;
- Crohn Disease;
- Calprotectin
Camille ZALLOT, MD
Seen in:
- Vandœuvre-lès-Nancy, CHRU Nancy
Trials:
- NCT03809728 (Sub-Investigator)
Conditions:
Caroline Trang
Seen in:
- Nantes, CHU NANTES - Hôpital Hôtel Dieu
- Nantes, Hopital privé Confluent
Trials:
- NCT04183608 (Principal Investigator)
- NCT05117996 (Principal Investigator)
Conditions:
- Ulcerative Colitis;
- Crohn Disease
Catherine Le Berre
Seen in:
- Cedex 1, Nantes, Chu Nantes
- Nantes Cedex 1, Chu Nantes
- Nantes, CHU de Nantes
- Nantes, Nantes University Hospital
Trials:
- NCT05117996 (Principal Investigator)
- NCT05767021 (Principal Investigator)
- NCT05903066 (Principal Investigator)
Conditions:
Cédric DURON
Seen in:
- Montluçon, Montluçon Hospital
Trials:
- NCT04973423 (Principal Investigator)
Conditions:
- MRI;
- Crohn Disease;
- Calprotectin
Charlotte BERGOIN, MD
Seen in:
- Pierre Benite, Service d'Hépato-Gastroentérologie, Centre Hospitalier Lyon-Sud, HCL
Trials:
- NCT03915262 (Sub-Investigator)
Conditions:
- Crohn Disease
Christophe Allimant
Seen in:
- Chambéry, Chambéry Hospital
Trials:
- NCT04973423 (Principal Investigator)
Conditions:
- MRI;
- Crohn Disease;
- Calprotectin
Clément PASTAUD
Seen in:
- Aurillac, Aurillac Hospital
Trials:
- NCT04973423 (Principal Investigator)
Conditions:
- MRI;
- Crohn Disease;
- Calprotectin
Clément Prati, Prof.
Seen in:
- Besançon, Charline Vauchy
Trials:
- NCT04191395 (Principal Investigator)
Conditions:
Corinne Gower, MD,PhD
Seen in:
- Lille, CHU Lille
Trials:
- NCT03706196 (Principal Investigator)
Conditions:
- Environmental Exposure
David Laharie
Seen in:
- Amiens, CHU Amiens
- Bordeaux, Bordeaux University Hospital
- Bordeaux, CHU de Bordeaux - Hopital Haut-Leveque
- Gironde, Pessac, CHU Bordeaux - Hôpital Haut-Lévêque
- Pessac, CHU Bordeaux - Hôpital Haut Lévêque
Trials:
- NCT04183608 (Principal Investigator)
- NCT04973423 (Principal Investigator)
- NCT05767021 (Principal Investigator)
- NCT05903066 (Principal Investigator)
- NCT05040464 (Principal Investigator)
Conditions:
- Ulcerative Colitis;
- MRI;
- Crohn Disease;
- Calprotectin;
- Ulcerative Colitis Chronic;
- Methotrexate;
- Azathioprine
Delphine Ley
Seen in:
- Nord, Lille Cedex, Hopital Jeanne de Flandre - CHRU Lille
Trials:
- NCT05509777 (Principal Investigator)
Conditions:
- Crohn's Disease

Clinical Trials on Crohn Disease

ProgenaBiome

Recruiting

A Pilot Study to Explore the Role of Gut Flora in Crohn's Disease

Crohn Disease | Crohn Colitis | Crohn's Ileocolitis | Crohn's Gastritis | Crohn's Jejunitis | Crohn's Duodenitis | Crohn's Esophagitis | Crohn's | Crohn Disease of Ileum | Crohn Ileitis | Crohn's Disease Relapse | Crohns Disease Aggravated | Crohn Disease in Remission | Crohn's Disease of Pylorus

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...
Celltrion

Recruiting

inDuctIon tREatment With subCuTaneous Infliximab for Crohn's Disease (DIRECTCD)

Bowel Disease | Inflammatory Disease | Disease Crohn

Netherlands
Chinese University of Hong Kong

Terminated

A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Response to Biological Therapy in Patients With CD

Crohn Disease | Perianal Crohn Disease

Hong Kong
Sandoz

Completed

Real-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s Disease (GIANT)

Crohn´s Disease

Austria, Germany, Poland, Spain, Sweden
Dr. Falk Pharma GmbH

Completed

9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease

Crohn´s Disease

Germany
University of Erlangen-Nürnberg Medical School

Completed

Endomicroscopy and Crohn´s Disease

Crohn´s Disease

Germany
Ferring Pharmaceuticals

Terminated

A Study With Pentasa in Patients With Active Crohn's Disease (PEACE)

Crohn´s Disease

United Kingdom, United States, Germany, Belgium, Denmark, France, Sweden
Groupe Hospitalier Paris Saint Joseph

Completed

Study of Photographs of Interest in Training to Obtain Good Reproducibility of the Diagnosis of Perianal Lesions of Crohn's Disease Inspection in Internal Gastroenterology (PhotoCrohn)

Crohn

France
Jinling Hospital, China

Completed

Exclusive Enteral Nutrition for Remissionof Crohn's Diseases After Surgery

Crohn Disease in Remission

China
Boehringer Ingelheim

Terminated

A Study to Test Whether Spesolimab Helps People With Crohn's Disease Who Have Symptoms of Bowel Obstruction

Fibrostenotic Crohn´s Disease

United States, Canada, Japan, Sweden

Medical specialists from France tagged as investigators in clinical trials studying Crohn Disease

Clinical Trials on Crohn Disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations